Skip to main content

Closed

ELUT: Elutia Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-49.6% / yr

Operating margin-159.4%

ROIC-78.3%

Financially safe

Strong

Debt / equity0.19×

Interest coverage8.6×

Current ratio2.05×

Valuation

Unrated

P/E ratio0.7×

Elutia Inc

ELUTNASDAQ Capital Market·USD·Closed

Elutia Inc

ELUTNASDAQ·USD·Closed

$0.86

−5.33%

$0.86

−$0.05 (5.33%)

52W Range

18thpctl

Volume

1.37×avg

Mkt Cap

37.88MUSD

P/E

0.7TTM

Div Yield

–ann

52W Range

18thpctl

Volume

1.37×avg

Market Cap

37.88MUSD

P/E Ratio

0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings